title: [Giant-cell arteritis: the clinico-biological manifestations and the complications secondary to steroid treatment].
abstract: The analysed clinico-biological manifestations, evolutive course and treatment of 30 patients with GCA are presented. The most frequent symptoms were fever and headache. 33% of patients had FOD criteria. 26% had various visual alterations. All patients were initially treated with steroids. Of the 26 patients followed up, 21 (81.7%) experienced some sort of complication: Cushing iatrogenic, osteoporosis, vertebrae collapse, aseptic necrosis of the femur head, arterial hypertension, diabetes mellitus, hyperlipidemia, steroid myopathy. 6 patients were treated with cyclophosphamide, following severe complications secondary to steroid therapy, and all of them had a good clinical evolution.
authors.affiliation: Servicio de Medicina Interna, Hospital La Paz, Universidad Autónoma de Madrid.
authors.forename: R
authors.initials: R
authors.lastname: de la Casa Monje
authors.forename: F J
authors.initials: FJ
authors.lastname: Barbado Hernández
authors.forename: J M
authors.initials: JM
authors.lastname: Peña Sánchez de Rivera
authors.forename: A
authors.initials: A
authors.lastname: Domínguez Castellano
authors.forename: A
authors.initials: A
authors.lastname: Sendino Revuelta
authors.forename: I
authors.initials: I
authors.lastname: González-Anglada
authors.forename: J J
authors.initials: JJ
authors.lastname: Vázquez Rodríguez
mesh_terms: D000305:Adrenal Cortex Hormones / Q000008:administration & dosage / Q000009:adverse effects*; D000368:Aged; D000369:Aged, 80 and over; D001706:Biopsy; D005260:Female; D013700:Giant Cell Arteritis / Q000150:complications / Q000175:diagnosis* / Q000188:drug therapy; D006801:Humans; D008297:Male; D008875:Middle Aged; D012008:Recurrence; D012189:Retrospective Studies; D013699:Temporal Arteries / Q000473:pathology; D013997:Time Factors
chemical_list: D000305:Adrenal Cortex Hormones
vernacular_title: Arteritis de células gigantes: manifestaciones clínico-biológicas y complicaciones secundarias al tratamiento esteroideo.